Skip to content

AngioDynamics

US · ANGO #3631 by market cap
10.81 +0.05 +0.46%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Recent news

  • Rating change
    H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14
    Market Newswire · 2024/12/10
  • H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Cuts Target Price to $18
    Market Newswire · 2026/10/14
  • Rating change
    Lake Street Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $24
    Market Newswire · 2026/1/7
  • Rating change
    Oppenheimer Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $16
    Market Newswire · 2025/1/10
  • Company notice
    Global Ltd: Notice of the opening of Kyoto 5 property Hotel Group Project "ENSO ANGO"
    JPX · 2018/10/16
  • Rating change
    H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $16
    Market Newswire · 2025/4/8
  • Rating change
    H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $15
    Market Newswire · 2025/1/10
  • Rating change
    CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $18
    Market Newswire · 2026/1/7
  • H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $19
    Market Newswire · 2026/7/16
  • Rating change
    CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $18
    Market Newswire · 2025/10/3
  • H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $19
    Market Newswire · 2026/7/16
  • Rating change
    CCORF Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $15
    Market Newswire · 2025/1/10
  • Rating change
    Freedom Capital Markets Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $16
    Market Newswire · 2026/4/6
  • Company notice
    Global Ltd: Notice on the change of the name of "ENSO ANGO" of Metropole Hotel
    JPX · 2020/2/28
  • Rating change
    Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), AngioDynamics (ANGO)
    TipRanks · 2026/5/29
  • H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $18
    Market Newswire · 2026/10/14
  • Lake Street Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $24
    Market Newswire · 2026/7/14
  • Rating change
    CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $17
    Market Newswire · 2025/8/13
  • Rating change
    CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $12
    Market Newswire · 2024/12/10
  • Rating change
    H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $16
    Market Newswire · 2026/4/6
  • Rating change
    AngioDynamics (ANGO) Gets a Buy From H.C. Wainwright
    TipRanks · 2024/10/4
  • Rating change
    Oppenheimer Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $13
    Market Newswire · 2024/10/5
  • Rating change
    CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Cuts Target Price to $12
    Market Newswire · 2024/10/4

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:01:15 · For reference only, not investment advice and not tailored to your situation.

AngioDynamics discussion 0 comments

Add a comment